Activity
| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
7 actions
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inherited ovarian cancer (without breast cancer) v4.8 | LLGL2 |
Arina Puzriakova Tag Q2_25_ promote_green was removed from gene: LLGL2. Tag Q2_25_ NHS_review was removed from gene: LLGL2. Tag to_be_confirmed_NHSE tag was added to gene: LLGL2. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inherited ovarian cancer (without breast cancer) v4.8 | LLGL2 | Arina Puzriakova commented on gene: LLGL2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inherited ovarian cancer (without breast cancer) v4.4 | LLGL2 |
Sarah Leigh Tag Q2_25_ promote_green tag was added to gene: LLGL2. Tag Q2_25_ NHS_review tag was added to gene: LLGL2. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inherited ovarian cancer (without breast cancer) v4.4 | LLGL2 | Sarah Leigh reviewed gene: LLGL2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: High-grade serous ovarian carcinoma; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inherited ovarian cancer (without breast cancer) v4.4 | LLGL2 | Sarah Leigh Classified gene: LLGL2 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inherited ovarian cancer (without breast cancer) v4.4 | LLGL2 | Sarah Leigh Gene: llgl2 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inherited ovarian cancer (without breast cancer) v4.3 | LLGL2 |
Riyaad Aungraheeta gene: LLGL2 was added gene: LLGL2 was added to Inherited ovarian cancer (without breast cancer). Sources: Literature Mode of inheritance for gene: LLGL2 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Publications for gene: LLGL2 were set to 39794353 Phenotypes for gene: LLGL2 were set to High-grade serous ovarian carcinoma Penetrance for gene: LLGL2 were set to unknown Review for gene: LLGL2 was set to AMBER Added comment: Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||